CA638995A - Therapeutic preparation - Google Patents

Therapeutic preparation

Info

Publication number
CA638995A
CA638995A CA638995A CA638995DA CA638995A CA 638995 A CA638995 A CA 638995A CA 638995 A CA638995 A CA 638995A CA 638995D A CA638995D A CA 638995DA CA 638995 A CA638995 A CA 638995A
Authority
CA
Canada
Prior art keywords
therapeutic preparation
therapeutic
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA638995A
Inventor
B. Wheatley William
L. Dickison Harry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Publication date
Application granted granted Critical
Publication of CA638995A publication Critical patent/CA638995A/en
Expired legal-status Critical Current

Links

CA638995A Therapeutic preparation Expired CA638995A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA638995T

Publications (1)

Publication Number Publication Date
CA638995A true CA638995A (en) 1962-03-27

Family

ID=35917505

Family Applications (1)

Application Number Title Priority Date Filing Date
CA638995A Expired CA638995A (en) Therapeutic preparation

Country Status (1)

Country Link
CA (1) CA638995A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5675037A (en) * 1990-12-17 1997-10-07 Rohm And Haas Company Selective acylation of hydrazines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5675037A (en) * 1990-12-17 1997-10-07 Rohm And Haas Company Selective acylation of hydrazines

Similar Documents

Publication Publication Date Title
CA638995A (en) Therapeutic preparation
CA643420A (en) Therapeutic aid
CA649038A (en) Therapeutic apparatus
CA641075A (en) Therapeutic composition
CA641715A (en) Therapeutic composition
CA642193A (en) Methyldihalogenosilane preparation
AU284752B2 (en) Novel therapeutic agent
CA636151A (en) Dermatological preparation
CA641716A (en) Therapeutic tablets
AU3794863A (en) Novel therapeutic agent
CA641080A (en) Medicator
CA654410A (en) Preparation of aminohaloboranes
AU288408B2 (en) Preparation of fluorochlorobenzenes
CA645626A (en) Preparation of tetra-fluorohydrazine
CA645574A (en) Preparation of dicyanogen
CA638294A (en) Preparation of isocyanogen tetrazide
CA635922A (en) Preparation of alkylcarbamoylmethyl dimethylphosphorodithioates
CA654262A (en) Preparation of alkylcyclohexyl-amines
AU276265B2 (en) Preparation of allyloxybenzenesulfonates
AU266321B2 (en) Preparation of tetrachloroxylylenediamines
AU263252B2 (en) Preparation of 3-chloro-caprolactam
CA647474A (en) Preparation of tetrachloro-m-alkylphenols
CA634996A (en) Chair
CA634084A (en) Cosmetic preparation
CA644733A (en) Cosmetic preparation